Skip to main content

GERD News

Related terms: Heartburn, Acid reflux, Esophageal Reflux, Gastroesophageal Reflux Disease, Pyrosis, Reflux, Heart Burn, Severe Heartburn

Phathom Pharmaceuticals Announces FDA Approval of Voquezna (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

FLORHAM PARK, N.J., July 18, 2024 (GLOBE NEWSWIRE) – Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...

Odds of IBS, Functional Dyspepsia Increased After Acute Gastroenteritis Episode

WEDNESDAY, July 17, 2024 – A considerable proportion of individuals experiencing acute gastroenteritis develop postinfection irritable bowel syndrome (PI-IBS) and postinfection functional dyspepsia...

Improved GERD Questionnaire Scores Seen With Antireflux Mucosectomy

WEDNESDAY, July 3, 2024 – For patients with refractory gastroesophageal reflux disease (GERD), those receiving antireflux mucosectomy (ARMS) have a greater improvement in the GERD questionnaire...

Gastroesophageal Reflux Disease Increases Risk for Atrial Fibrillation

TUESDAY, July 2, 2024 – Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2 in Frontiers in ...

Novel Score Validated for Diagnosis of Gastroesophageal Reflux Disease

MONDAY, May 6, 2024 – A novel high-resolution manometry (HRM) score can stratify the risk and severity of gastroesophageal reflux disease (GERD), according to a study published online March 27 in...

Use of Acid-Suppression Therapy Linked to Migraine, Severe Headache

FRIDAY, April 26, 2024 – Use of acid-suppression therapy is associated with higher odds of migraine or severe headache, according to a study published online April 24 in Neurology: Clinical...

Could Heartburn Meds Raise Your Migraine Risk?

THURSDAY, April 24, 2024 – People taking heartburn meds have a higher risk of migraines and other types of severe headaches, a new study warns. All classes of acid-reducing drugs – proton pump...

Anxiety, Depression Associated With Gastroesophageal Reflux Disease

TUESDAY, April 2, 2024 – Anxiety and depression are associated with an increased incidence of gastroesophageal reflux disease (GERD), according to a study published online March 19 in Scientific...

Validated COuGH RefleX Score Can Predict Likelihood of GERD

WEDNESDAY, March 6, 2024 – The validated Cough, Overweight/Obesity, Globus, Hiatal Hernia, Regurgitation, and Male Sex (COuGH RefluX) score can predict the likelihood of proven gastroesophageal...

GERD Can Induce Occurrence of Rheumatoid Arthritis, but Not Vice Versa

WEDNESDAY, Jan. 31, 2024 – Gastroesophageal reflux disease (GERD) causally and positively influences rheumatoid arthritis (RA), but RA has no significant influence on GERD, according to a study...

pH-Multichannel Intraluminal Impedance Monitoring Can ID GERD

FRIDAY, Dec. 29, 2023 – For preschool-aged children, pH-multichannel intraluminal impedance (MII) monitoring is useful for diagnosing gastroesophageal reflux disease (GERD)-related wheezing,...

GERD Is Common Indication for Revisional Bariatric Surgery

FRIDAY, Dec. 1, 2023 – For patients who have undergone bariatric surgery for gastroesophageal reflux disease (GERD), revision surgery is common and is mainly with a Roux-en-Y gastric bypass (RYGB),...

Got GERD? Eat This Way to Help Avoid Symptoms

FRIDAY, Nov. 24, 2023 – Some folks feasting this holiday have to contend with gastroesophageal reflux disease, also known as GERD. In fact, about one-third of the population is affected by this...

Antireflux Mucosal Ablation Safe, Effective for Refractory Reflux Disease

MONDAY, Nov. 6, 2023 – Antireflux mucosal ablation (ARMA) cuts short-term gastroesophageal reflux disease (GERD) symptoms in two-thirds of patients undergoing the endoscopic treatment, according to...

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults

FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) – Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Barrett's Esophagus, Indigestion

Related drug support groups

omeprazole, pantoprazole, Nexium, Pepcid, Prilosec, sucralfate, Carafate, famotidine, Protonix, view more... Tums, lansoprazole, Dexilant, Pepcid AC, Zantac, Heartburn Relief, esomeprazole